We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$60.9B
AUM Growth
-$821M
(-1.3%)
Cap. Flow
-$3.18B
Cap. Flow
% of AUM
-5.23%
Top 10 Holdings %
Top 10 Hldgs %
24.34%
Holding
1,619
New
432
Increased
351
Reduced
430
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$487M |
| 2 |
Kimberly-Clark
KMB
|
+$223M |
| 3 |
Norfolk Southern
NSC
|
+$217M |
| 4 |
Boeing
BA
|
+$167M |
| 5 |
Caterpillar
CAT
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YPF
YPF
|
+$362M |
| 2 |
ICICI Bank
IBN
|
+$270M |
| 3 |
Chevron
CVX
|
+$239M |
| 4 |
AABA
Altaba Inc
AABA
|
+$238M |
| 5 |
Citizens Financial Group
CFG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 15.67% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 13.12% |
| 5 | Communication Services | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Truist Financial
TFC
$63.3B
| $23M | 0.04% |
430,994
-18,362
| -4% | -$910K |
|
277
iShares MSCI EAFE ETF
EFA
$78B
| $22.5M | 0.04% |
345,607
-133,248
| -28% | -$8.59M |
|
278
Costco
COST
$422B
| $22.5M | 0.04% |
78,096
-12,367
| -14% | -$3.48M |
|
279
Simply Good Foods
SMPL
$901M
| $22.5M | 0.04% |
775,242
+548,742
| +242% | +$15.3M |
|
280
Wells Fargo
WFC
$261B
| $22.3M | 0.04% |
442,168
-386,353
| -47% | -$18.2M |
|
|
AVNS
281
DELISTED
Avanos Medical
AVNS
| $22.2M | 0.04% |
592,564
-23,267
| -4% | -$888K |
|
282
PENN Entertainment
PENN
$2.75B
| $22.2M | 0.04% |
1,190,855
+171,640
| +17% | +$3.25M |
|
283
ExxonMobil
XOM
$644B
| $22.1M | 0.04% |
313,526
-269,224
| -46% | -$19.5M |
|
284
Gilead Sciences
GILD
$162B
| $22.1M | 0.04% |
348,025
+67,995
| +24% | +$4.44M |
|
|
B
285
Barrick Mining
B
$61.5B
| $21.8M | 0.04% |
1,259,734
-355,697
| -22% | -$6.28M |
|
|
CTLT
286
DELISTED
CATALENT, INC.
CTLT
| $21.8M | 0.04% |
457,030
-191,579
| -30% | -$10.3M |
|
287
HCA Healthcare
HCA
$87.2B
| $21.8M | 0.04% |
180,761
+90,798
| +101% | +$11.7M |
|
288
Encompass Health
EHC
$11B
| $21.7M | 0.04% |
431,049
+235,479
| +120% | +$11.8M |
|
289
LCI Industries
LCII
$2.49B
| $21.7M | 0.04% |
236,006
+800
| +0.3% | +$71.1K |
|
290
Biogen
BIIB
$30B
| $21.6M | 0.04% |
92,836
+1,563
| +2% | +$364K |
|
|
PXD
291
DELISTED
Pioneer Natural Resource Co.
PXD
| $21.6M | 0.04% |
171,720
+7,610
| +5% | +$1.01M |
|
292
Adobe
ADBE
$99.5B
| $21.6M | 0.04% |
78,140
-69,660
| -47% | -$20.3M |
|
|
AZUL
293
DELISTED
Azul
AZUL
| $21.6M | 0.04% |
602,434
-2,069
| -0.3% | -$77.4K |
|
294
Micron Technology
MU
$930B
| $21.2M | 0.03% |
494,154
+313,511
| +174% | +$14.2M |
|
295
Cencora
COR
$60.6B
| $20.8M | 0.03% |
252,408
+221,616
| +720% | +$19M |
|
296
Leggett & Platt
LEG
$1.34B
| $20.5M | 0.03% |
501,541
-128,116
| -20% | -$5.03M |
|
297
Agnico Eagle Mines
AEM
$73.6B
| $20.4M | 0.03% |
380,328
-77,027
| -17% | -$4.36M |
|
298
Itaú Unibanco
ITUB
$93.2B
| $20.4M | 0.03% |
3,331,767
+23,732
| +0.7% | +$154K |
|
299
Synchrony
SYF
$24.7B
| $20.3M | 0.03% |
594,327
-280,084
| -32% | -$9.61M |
|
300
Columbus McKinnon
CMCO
$553M
| $20.2M | 0.03% |
555,798
-106,472
| -16% | -$3.95M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Lazard Asset Management held 1,619 positions worth $60.9B, down 1.3% from $61.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.18B in Q3 2019, closing 152 positions and reducing 430 holdings. Its most notable exit was Altaba Inc, an estimated $238M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Genmab worth $34.3M.
- Lazard Asset Management's largest Q3 2019 buy was Genmab: 1,694,121 shares worth $34.3M.
- Lazard Asset Management added most to CSX Corp in Q3 2019, an estimated $487M increase.
- Lazard Asset Management's biggest Q3 2019 reduction was YPF, cutting an estimated $362M.
- Lazard Asset Management fully exited Altaba Inc in Q3 2019, selling an estimated $238M.
- Lazard Asset Management's ten largest holdings make up 24% of its $60.9B portfolio in Q3 2019.
- Lazard Asset Management opened 432 new positions and closed 152 in Q3 2019.
- Lazard Asset Management's portfolio value fell 1.3% quarter-over-quarter to $60.9B.
Based on Lazard Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.